Artigo
Nitrergic pathways and L-type calcium channel of MnPO influencing cardiovascular homeostasis
Date
2006-07-01Registration in:
Journal of Medical Sciences, v. 6, n. 4, p. 597-602, 2006.
1682-4474
1812-5727
10.3923/jms.2006.597.602
2-s2.0-33750375543
Author
Universidade de Taubaté (UNITAU)
Centro Universitário de Araraquara (UNIARA)
Universidade Estadual Paulista (Unesp)
Universidade Federal de São Carlos (UFSCar)
Universidade de São Paulo (USP)
Abstract
The median preoptic nucleus (MnPO) is one of most important site of the lamina terminalis implicated in the regulation of hydro electrolytic and cardiovascular balance. The purpose of this study was to determine the effect of L-Type calcium channel antagonist, nifedipine, on the increase of median arterial blood pressure (MAP) induce by angiotensin II (ANG II) injected into the MnPO. The influence of nitric oxide (NO) on nifedipine antipressor action has also been studied by utilizing N W-nitro-L-arginine methyl ester (L-NAME) (40 μg 0.2 μL -1) a NO synthase inhibitor (NOSI), 7-nitroindazole (7-NIT) (40 μg 0.2 μL -1), a specific neuronal NO synthase inhibitor (nNOSI) and sodium nitroprusside (SNP) (20 μg 0.2 μL -1) a NO donor agent. We have also investigated the central role of losartan and PD123349 (20 nmol 0.2 μL -1), AT 1 and AT 2, respectively (selective non peptide ANG II receptor antagonists), in the pressor effect of ANG II (25 pmol 0.2 μL -1) injected into the MnPO. Male Wistar rats weighting 200-250 g, with cannulae implanted into the MnPO were utilized. Losartan injected into the MnPO, prior to ANG II, blocked the pressor effect of ANGII. PD 123319 only decreased the pressor effect of ANG II. Rats pre-treated with either 50 μg 0.2 μL -1 or 100 μg 0.2 μL -1 of nifedipine, followed by 25 pmol 0.2 μL -1 of ANG II, decreased ANG II-pressor effect. L-NAME potentiated the pressor effect of ANG II. 7-NIT injected prior to ANG II into the MnPO also potentiated the pressor effect of ANGII but with less intensity than that of L-NAME. SNP injected prior to ANG II blocked the pressor effect of ANG II. The potentiation action of L-NAME and 7-NIT on ANG II-pressor effect was blocked by prior injection of nifedipine. The results described in this study provide evidence that calcium channels play important roles in central ANG II-induced pressor effect. The structures containing NO in the brain, such as MnPO, include both endothelial and neuronal cells, which might be responsible for the influence of nifedipine on the pressor effect of ANG II. These data have shown the functional relationship between L-Type calcium channel and a free radical gas NO in the MnPO, on the control of ANG II-induced pressor effect acting in AT 1 and AT 2 receptors.
Subjects
Related items
Showing items related by title, author, creator and subject.
-
Aerobic Exercise Training-Induced Left Ventricular Hypertrophy Involves Regulatory MicroRNAs, Decreased Angiotensin-Converting Enzyme-Angiotensin II, and Synergistic Regulation of Angiotensin-Converting Enzyme 2-Angiotensin (1-7)
FERNANDES, Tiago; HASHIMOTO, Nara Y.; MAGALHAES, Flavio C.; FERNANDES, Fernanda B.; CASARINI, Dulce E.; CARMONA, Adriana K.; KRIEGER, Jose E.; PHILLIPS, M. Ian; OLIVEIRA, Edilamar M. (LIPPINCOTT WILLIAMS & WILKINS, 2011)Aerobic exercise training leads to a physiological, nonpathological left ventricular hypertrophy; however, the underlying biochemical and molecular mechanisms of physiological left ventricular hypertrophy are unknown. The ... -
New specific angiotensin antagonists - [8-valine]-angiotensins i, [8-isoleucine]-angiotensins I, and chlorambucil-des-1-aspartic,8-valine-angiotensins I
Paiva, Antonio Cechelli de Mattos [UNIFESP]; NOUAILHE.VL; Miyamoto, M. E.; Bergsten-Mendes, Gun [UNIFESP]; Paiva, Therezinha Bandiera [UNIFESP] (Amer Chemical Soc, 1973-01-01) -
Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: A living systematic review of randomized clinical trialsAngiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: A living systematic review of randomized clinical trials
Meza, Nicolás; Pérez-Bracchiglione, Javier; Pérez, Ignacio; Carvajal, Cristhian; Ortiz Muñoz, Luis Eugenio; Olguín, Pablo; Rada Giacaman, Gabriel Alejandro; Madrid, Eva (2021)Objective: This living systematic review aims to provide a timely, rigorous, and continuously updated summary of the evidence available on the role of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II ...